Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women

INTRODUCTION: Combination antiretroviral therapy (cART) can effectively prevent vertical transmission of HIV but there is potential risk of adverse maternal, foetal or infant effects. Specifically, the effect of cART use during pregnancy on mitochondrial DNA (mtDNA) content in HIV-positive (HIV+) wo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Money, Deborah M., Wagner, Emily C., Maan, Evelyn J., Chaworth-Musters, Tessa, Gadawski, Izabelle, van Schalkwyk, Julie E., Forbes, John C., Burdge, David R., Albert, Arianne Y. K., Lohn, Zoe, Côté, Hélène C. F.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4527775/
https://ncbi.nlm.nih.gov/pubmed/26247211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0135041
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars